Otsuka Pharmaceutical Co, Ltd., and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority (six month review target) review the supplemental New Drug Application (sNDA) of the atypical antipsychotic ABILIFY? (aripiprazole) for the treatment of pediatric patients (13-17 years old) with schizophrenia.
Researchers at the University of Leeds (UK) have found a mechanism to prevent a potentially fatal heart condition that can strike without warning.
An intensive form of talk therapy, known as transference-focused psychotherapy (TFP), can help individuals affected with borderline personality disorder (BPD) by reducing symptoms and improving their social functioning, according to an article in the June issue of the American Journal of Psychiatry, a premier psychiatry journal.
The use of an electronic medical record (EMR) in primary care practices is insufficient for insuring high-quality diabetes care finds this study of 927 diabetic patients in 50 primary care practices.
The World Health Organization (WHO) today warmly welcomed the United States’ proposal to commit a further $30 billion to the President’s Emergency Plan for AIDS Relief and extend the Plan for another five years.
More than 78 percent of living right liver donors experienced post-operative complications, according to a new study that uses a replicable complication classification system.
Women on tamoxifen therapy who reported having hot flashes were less likely to develop recurrent breast cancer than those who did not report hot flashes, according to a study from the Moores Cancer Center at the University of California, San Diego (UCSD).
Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.
Genetic variations may help explain why some men with depression develop suicidal thoughts and behaviors after they begin taking antidepressant medications, while most do not, according to a report in the June issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
A new study in Annals of Internal Medicine shows that use of antipsychotic drugs is associated with an early and sustained increase in risk of death when used to treat disruptive behavior of older adults with dementia.